EGFR and prostate carcinoma: EGFR overexpression is correlated with the increased aggressiveness, metastases, and poor prognosis in various cancers [39], including head and neck cancer, colorectal cancer, pancreatic, lung cancer, renal cell, prostate carcinoma and malignant glioma [40–41].